The authors newly define the ’low-risk’ group of patients as having a recurrence score of ≤10, compared to the higher ‘standard’ cutoff score of <18 for low-risk designation. Is there strong enough evidence to continue to define the low-risk group as ≤10, or should it remain higher (e.g. <18) until there is clear evidence that the group of patients with a recurrence score of 11-17 are mid-range risk, and not low-risk?
Easy one-click social registrationIs this safe?
We only receive the minimum information necessary to verify your account. We never get access to your friends/contacts or your profile, and we never post on your behalf. Your social account is used for logging in only.ORRegister via email
Send me updates on this Contest
In order to ensure a fair voting process and to make sure that no one votes more than once, we ask that you register either with a social networking account (easiest, only requires one click) or by registering with your email address (this will require you to click on a verification email that we will send you).
You only need to register once.